Drug Database
Back to search

United States· US:63323-723_406a07e3-a3f8-4fef-901e-021d00743c40

Remifentanil Hydrochloride

A remifentanil product containing remifentanil hydrochloride, registered in United States by Fresenius Kabi USA, LLC. The same ATC class is registered in 18 of our 19 countries.

ATC N01AH06US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedRemifentanil HydrochlorideATCN01AH06REGISTER NO.US:63323-723_406a07e3…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about remifentanil hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Remifentanil is registered in 18 of 19 countries.

Countries holding a registration under ATC N01AH06 (remifentanil), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose
Search remifentanil products by name

Remifentanil · ATC N01AH06

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of remifentanil costs, country by country.

Normalised to the WHO defined daily dose (52.5 mcg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Remifentanil · price per daily dose (52.5 mcg)

USD · FX 28 Sept 2026

  • FI Finland$0.30
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
REMIFENTANIL HYDROCHLORIDE
Manufacturer
Fresenius Kabi USA, LLC
Country
United States (US)
ATC code
N01AH06
ATC class
Remifentanil
Defined daily dose
52.5 mcg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    63323-723-06
  • ndc11
    6332372306
    10 VIAL, SINGLE-DOSE in 1 CARTON (63323-723-06) / 3 mL in 1 VIAL, SINGLE-DOSE (63323-723-04)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

123 interactions on record for remifentanil.

Graded by severity as the source publishes them — 18 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check remifentanil against other medicinesHow interaction checks work

Remifentanil · interactions on record

123 records

  • 18 severe
  • 91 moderate
  • 14 info

Most severe, free to view

  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • PalonosetronA04AA05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Remifentanil in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All remifentanil products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Remifentanil Hameln, Remifentanil Kabi
  • Belgium · Ultiva
  • Bulgaria · Ремифентанил Хамелн, Ремифентанил-Чайкафарма
  • Cyprus · Refenta
  • Czechia · Remifentanil B. Braun
  • Germany · Remifentanil B. Braun, Remifentanil Genmed
  • Denmark · Remifentanil B. Braun, Remifentanil Fresenius Kabi
  • Estonia · Remifentanil Kabi
  • Spain · Remifentanilo Kern Pharma, Remifentanilo Noridem
  • Finland · Remifentanil, Remifentanil B. Braun
  • France · Remifentanil Piramal, Remifentanil Viatris
  • United Kingdom (Northern Ireland) · Remifentanil, Remifentanil B. Braun
  • Greece · Dormiden, Remifentanil Anfarm
  • Croatia · Remifentanil Hameln
  • Ireland · Remifentanil, Remifentanil Fresenius Kabi Deutschland
  • Iceland · Remifentanil Hameln
  • Italy · Remifentanil Hameln, Remifentanil Mylan Generics
  • Lithuania · Remifentanil Kabi
  • Luxembourg · Ultiva
  • Latvia · Remifentanil Kabi
  • Malta · Remifentanil Anfarm, Remifentanil Noridem
  • Netherlands · Remifentanil B. Braun, Remifentanil Fresenius Kabi
  • Norway · Remifentanil Hameln, Remifentanil Orion
  • Poland · Ultiva
  • Portugal · Remifentanilo Accord, Remifentanilo Asklepius
  • Romania · Remifentanil Kabi
  • Sweden · Remifentanil B. Braun, Remifentanil Hameln
  • Slovenia · Remifentanil Hameln
  • Slovakia · Remifentanil B. Braun, Ultiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c92c5545-de82-4986-9234-9e0dda31d153
GET /v1/drugs/c92c5545-de82-4986-9234-9e0dda31d153?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "1",
  "substance": "REMIFENTANIL HYDROCHLORIDE",
  "productndc": "63323-723",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": "CII",
  "strength_unit": "mg/mL",
  "application_number": "ANDA206223",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about remifentanil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console